High indinavir plasma concentrations in HIV-positive patients co-infected with hepatitis B or C virus treated with low doses of indinavir and ritonavir (400/100 mg twice a day) plus two nucleoside reverse transcriptase inhibitors

AIDS. 2003 May 2;17(7):1108-10. doi: 10.1097/00002030-200305020-00030.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • AIDS-Related Opportunistic Infections / complications*
  • Drug Therapy, Combination
  • HIV Infections / blood
  • HIV Infections / drug therapy
  • HIV Protease Inhibitors / administration & dosage*
  • HIV Protease Inhibitors / blood
  • Hepatitis B, Chronic / complications*
  • Hepatitis C, Chronic / complications*
  • Humans
  • Indinavir / administration & dosage*
  • Indinavir / blood
  • Reverse Transcriptase Inhibitors / administration & dosage
  • Ritonavir / administration & dosage

Substances

  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Indinavir
  • Ritonavir